NCT02065440

The Effect of Ebastine/Pseudoephedrine on Subacute Cough

The Effect of Ebastine/Pseudoephedrine on Subacute Cough :a Randomized Placebo-controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 130 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

To determine whether ebastine/pseudoephedrine is effective on subacute cough.

Detailed description

1. Visit 0 week * Patients with subacute cough,area randomized to either ebastine/pseudoephedrine or placebo for 1 week. * The cough severity and quality of life were measure with VAS score and cough-specific quality-of-life questionnaire(CQLQ) 2. Visit 1 week check VAS score and CQLQ 3. Visit 4 weeks check VAS score and CQLQ

Conditions

• Cough

Interventions

Type	Name	Description
DRUG	Rhinoebastel	Rhinoebastel(ebastine 10mg/pseudoephedrine 120mg) 1 cap/day for 1 week unless progression or unacceptable toxicity develops.
DRUG	Placebo	Placebo 1 cap/day for 1 week unless progression or unacceptable toxicity develops

Timeline

• Start date: 2011-09-01
• Primary completion: 2014-02-01
• First posted: 2014-02-19
• Last updated: 2014-02-19

Locations

1 site across 1 country: South Korea